Lexeo Therapeutics, Inc. · NASDAQ:LXEO
The Vanguard Group reported a 5.33% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.33% stake in Lexeo Therapeutics, Inc., 3,894,310 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.33%
- Shares
- 3,894,310
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.33% | 3,894,310 |
Source
Related
- Lexeo Therapeutics, Inc.
- The Vanguard Group
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026